
Bioorganic and Medicinal Chemistry Letters p. 765 - 770 (1999)
Update date:2022-08-03
Topics:
Luthin, David R.
Rabinovich, Aleksandr K.
Bhumralkar, Dilip R.
Youngblood, Kenna L.
Bychowski, Richard A.
Dhanoa, Daljit S.
John M, May
A novel series of derivatives of oxo-7H-benzo[e]perimidine-4-carboxylic acid (I) potently displaced radioligand binding of 125I-CRF to both CRF1 and CRF2 receptors. The members of this series antagonized CRF-stimulated cAMP formation and CRF-stimulated corticotropin release from rat pituitary in vivo. These are the first nonpeptide antagonists to show activity at both CRF1 and CRF2 receptors.
View MoreShanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd,Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Shanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
SHANXI XINTIANYUAN PHARMACEUTICAL CO., LTD.
website:http://www.tychemical.com
Contact:0086-358-3521713 3521715
Address:No. 1 Yintong Road, Shanxi Jiaocheng Economic Development Zone, Xiajiaying Town, Jiaocheng County, Lvliang City, Shanxi Province, China
Contact:+44 (0)161 367 9441
Address:
Doi:10.1016/S0968-0896(02)00131-1
(2002)Doi:10.1021/ol301566f
(2012)Doi:10.1016/j.tet.2011.05.034
(2011)Doi:10.1021/ja01632a019
(1954)Doi:10.1039/b203891a
(2002)Doi:10.1021/ja027670k
(2003)